{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:14:03Z","timestamp":1791296043371,"version":"4.1.0"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104836"],"award-info":[{"award-number":["82104836"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2023JJ60482"],"award-info":[{"award-number":["2023JJ60482"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ1007"],"award-info":[{"award-number":["2024JJ1007"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019413","name":"Yunnan Provincial Department of Education Science Research Fund Project","doi-asserted-by":"publisher","award":["X202410541204"],"award-info":[{"award-number":["X202410541204"]}],"id":[{"id":"10.13039\/501100019413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019413","name":"Yunnan Provincial Department of Education Science Research Fund Project","doi-asserted-by":"publisher","award":["23B0391"],"award-info":[{"award-number":["23B0391"]}],"id":[{"id":"10.13039\/501100019413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2023TJ-N22"],"award-info":[{"award-number":["2023TJ-N22"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117210","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:15:05Z","timestamp":1754450105000},"page":"117210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P3","title":["SLC6 transporters as pharmacological targets in depression: Molecular mechanisms and therapeutic strategies"],"prefix":"10.1016","volume":"242","author":[{"given":"Tianyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingchang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117210_b0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-clinpsy-072220-021440","article-title":"Major depression and its recurrences: life course matters. (in eng)","volume":"18","author":"Monroe","year":"2022","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"10.1016\/j.bcp.2025.117210_b0010","unstructured":"World Health Organization. \u201cDepressive disorder (depression).\u201d https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression (accessed)."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2024.5756","article-title":"Management of depression in adults: A review. (in eng)","volume":"332","author":"Simon","year":"2024","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.bcp.2025.117210_b0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.12968\/bjon.2023.32.14.678","article-title":"A clinical review of antidepressants, their sexual side-effects, post-SSRI sexual dysfunction, and serotonin syndrome. (in eng)","volume":"32","author":"Marks","year":"2023","journal-title":"Br. J. Nurs."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/pharmrev.123.000886","article-title":"The SLC6A15-SLC6A20 neutral amino acid transporter subfamily: functions, diseases, and their therapeutic relevance. (in eng)","volume":"76","author":"Kuku\u0142owicz","year":"2023","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2025.117210_b0030","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1021\/acs.jmedchem.9b01237","article-title":"The druggability of solute carriers. (in eng)","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117210_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2020.04.126","article-title":"\u03b3-Aminobutyric acid transporters as relevant biological target: Their function, structure, inhibitors and role in the therapy of different diseases. (in eng)","author":"\u0141\u0105tka","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bcp.2025.117210_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108369","article-title":"Blockade of GABA transporter-1 and GABA transporter-3 in the lateral habenula improves depressive-like behaviors in a rat model of Parkinson's disease. (in eng)","volume":"181","author":"Lyu","year":"2020","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0045","doi-asserted-by":"crossref","first-page":"841","DOI":"10.14336\/AD.2024.0328","article-title":"Role of serotonylation and SERT posttranslational modifications in alzheimer's disease pathogenesis. (in eng)","volume":"16","author":"Reddy","year":"2024","journal-title":"Aging Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bja.2024.08.043","article-title":"Reactive astrocytes mediate postoperative surgery-induced anxiety through modulation of GABAergic signalling in the zona incerta of mice. (in eng)","volume":"134","author":"Tong","year":"2025","journal-title":"Br. J. Anaesth."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00221-022-06530-4","article-title":"\u201cSarcosine (glycine transporter inhibitor) attenuates behavioural and biochemical changes induced by ketamine, in the rat model of schizophrenia. (in eng)","volume":"241","author":"Kumar","year":"2023","journal-title":"Exp. Brain Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0060","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.107436","article-title":"Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: A novel mechanism for the pathogenesis of Parkinson's disease. (in eng)","volume":"15","author":"Liang","year":"2025","journal-title":"Theranostics"},{"issue":"7754","key":"10.1016\/j.bcp.2025.117210_b0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-019-1135-1","article-title":"Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport. (in eng)","volume":"569","author":"Coleman","year":"2019","journal-title":"Nature"},{"issue":"8026","key":"10.1016\/j.bcp.2025.117210_b0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41586-024-07719-z","article-title":"Molecular basis of human noradrenaline transporter reuptake and inhibition. (in eng)","volume":"632","author":"Tan","year":"2024","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0075","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jnc.16179","article-title":"Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site. (in eng)","volume":"168","author":"Pedersen","year":"2024","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.bcp.2025.117210_b0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41594-023-01011-w","article-title":"Cryo-EM structure of GABA transporter 1 reveals substrate recognition and transport mechanism. (in eng)","volume":"30","author":"Nayak","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0085","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41467-025-57613-z","article-title":"Modulation of the human GlyT1 by clinical drugs and cholesterol. (in eng)","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117210_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphys.2024.100125","article-title":"\u201cAllosteric modulation of serotonin and dopamine transporters: new insights from computations and experiments (in eng)","volume":"7","author":"Nguyen","year":"2024","journal-title":"Curr. Res. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117210_b0095","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.cell.2025.01.015","article-title":"Solute carriers: the gatekeepers of metabolism. (in eng)","volume":"188","author":"Khan","year":"2025","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0100","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","article-title":"Targeting SLC transporters: small molecules as modulators and therapeutic opportunities. (in eng)","volume":"48","author":"Schlessinger","year":"2023","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.bcp.2025.117210_b0105","doi-asserted-by":"crossref","unstructured":"K. \u0141\u0105tka and M. Bajda, \u201cAnalysis of Binding Determinants for Different Classes of Competitive and Noncompetitive Inhibitors of Glycine Transporters. (in eng), Int J Mol Sci. 23, no. 14. 2022, doi: 10.3390\/ijms23148050.","DOI":"10.3390\/ijms23148050"},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/jpp\/rgae051","article-title":"In silico evidence of bitopertin's broad interactions within the SLC6 transporter family. (in eng)","volume":"76","author":"de Carvalho","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1476-5381.2012.01975.x","article-title":"The solute carrier 6 family of transporters. (in eng)","volume":"167","author":"Br\u00f6er","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0120","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1039\/C6MD00005C","article-title":"SLC transporters, structure, function, and Drug Discovery. (in eng)","volume":"7","author":"Colas","year":"2016","journal-title":"Medchemcomm"},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/pr.108.000869","article-title":"SLC6 neurotransmitter transporters: structure, function, and regulation. (in eng)","volume":"63","author":"Kristensen","year":"2011","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2025.117210_b0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41583-019-0151-3","article-title":"\u201cEmbracing diversity in the 5-HT neuronal system. (in eng)","volume":"20","author":"Okaty","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117210_b0135","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nn.4642","article-title":"Modular organization of the brainstem noradrenaline system coordinates opposing learning states. (in eng)","volume":"20","author":"Uematsu","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0140","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0278-5846(03)00150-7","article-title":"\u201cStrain differences in the distribution of dopamine transporter sites in rat brain. (in eng)","volume":"27","author":"Jiao","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0145","doi-asserted-by":"crossref","unstructured":"B. J. Ciliax et al. Immunocytochemical localization of the dopamine transporter in human brain. (in eng), J Comp Neurol. 409, no. 1, pp. 38-56. 1999, doi: 10.1002\/(sici)1096-9861(19990621)409:1<38::aid-cne4>3.0.co;2-1.","DOI":"10.1002\/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1"},{"issue":"4","key":"10.1016\/j.bcp.2025.117210_b0150","doi-asserted-by":"crossref","first-page":"750","DOI":"10.2174\/0929867325666191010120236","article-title":"Development, recent achievements and current directions of research into GABA uptake inhibitors. (in eng)","volume":"28","author":"Zar\u0119ba","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117210_b0155","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fchem.2018.00397","article-title":"\u201cStructure, Function, and Modulation of \u03b3-Aminobutyric Acid Transporter 1 (GAT1) in Neurological Disorders: A Pharmacoinformatic Prospective. (in eng)","volume":"6","author":"Zafar","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.bcp.2025.117210_b0160","doi-asserted-by":"crossref","unstructured":"W. Kilb and S. Kirischuk, \u201cGABA Release from Astrocytes in Health and Disease. (in eng), Int J Mol Sci. 23, no. 24. 2022, doi: 10.3390\/ijms232415859.","DOI":"10.3390\/ijms232415859"},{"issue":"45","key":"10.1016\/j.bcp.2025.117210_b0165","doi-asserted-by":"crossref","first-page":"37745","DOI":"10.1074\/jbc.M112.388157","article-title":"High selectivity of the \u03b3-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach. (in eng)","volume":"287","author":"Schlessinger","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"27","key":"10.1016\/j.bcp.2025.117210_b0170","doi-asserted-by":"crossref","first-page":"19331","DOI":"10.1074\/jbc.M702111200","article-title":"\u201cCloning and characterization of a functional human gamma-aminobutyric acid (GABA) transporter, human GAT-2. (in eng)","volume":"282","author":"Christiansen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117210_b0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neubiorev.2020.07.025","article-title":"Neurobiology of glycine transporters: from molecules to behavior. (in eng)","volume":"118","author":"Marques","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.bcp.2025.117210_b0180","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00429-018-1684-3","article-title":"GlyT1 determines the glycinergic phenotype of amacrine cells in the mouse retina. (in eng)","volume":"223","author":"Eulenburg","year":"2018","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.bcp.2025.117210_b0185","doi-asserted-by":"crossref","unstructured":"S. N. Mostyn et al. Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics. (in eng), Elife. 8. 2019, doi: 10.7554\/eLife.47150.","DOI":"10.7554\/eLife.47150"},{"key":"10.1016\/j.bcp.2025.117210_b0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-1-0716-1554-6_8","article-title":"The Structure and mechanism of drug transporters. (in eng)","volume":"2342","author":"Roberts","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bcp.2025.117210_b0195","article-title":"Overview of the structure and function of the dopamine transporter and its protein interactions","volume":"14","author":"Nepal","year":"2023","journal-title":"(in eng), Front Physiol"},{"key":"10.1016\/j.bcp.2025.117210_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70034","article-title":"Exploring the structural dynamics of LeuT using EPR spectroscopy: A focus on transmembrane helix 10. (in eng)","volume":"169","author":"Tsalagradas","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117210_b0205","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-biophys-083012-130429","article-title":"Common folds and transport mechanisms of secondary active transporters. (in eng)","volume":"42","author":"Shi","year":"2013","journal-title":"Annu. Rev. Biophys."},{"issue":"7474","key":"10.1016\/j.bcp.2025.117210_b0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature12533","article-title":"X-ray structure of dopamine transporter elucidates antidepressant mechanism. (in eng)","volume":"503","author":"Penmatsa","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117210_b0215","doi-asserted-by":"crossref","unstructured":"S. G. Schmidt, A. Nygaard, J. A. Mindell, and C. J. Loland, \u201cExploring the K(+) binding site and its coupling to transport in the neurotransmitter:sodium symporter LeuT. (in eng), Elife. 12. 2024, doi: 10.7554\/eLife.87985.","DOI":"10.7554\/eLife.87985.3"},{"issue":"19","key":"10.1016\/j.bcp.2025.117210_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167746","article-title":"Principles of alternating access in Leut-fold transporters: commonalities and divergences. (in eng)","volume":"434","author":"Del Alamo","year":"2022","journal-title":"J. Mol. Biol."},{"issue":"30","key":"10.1016\/j.bcp.2025.117210_b0225","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0804659105","article-title":"Mechanism for alternating access in neurotransmitter transporters. (in eng)","volume":"105","author":"Forrest","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117210_b0230","doi-asserted-by":"crossref","unstructured":"J. Fan et al. Crystal structures of LeuT reveal conformational dynamics in the outward-facing states. (in eng), J Biol Chem. 296, p. 100609, Jan-Jun 2021, doi: 10.1016\/j.jbc.2021.100609.","DOI":"10.1016\/j.jbc.2021.100609"},{"issue":"7056","key":"10.1016\/j.bcp.2025.117210_b0235","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature03978","article-title":"Crystal structure of a bacterial homologue of Na+\/Cl\u2013dependent neurotransmitter transporters. (in eng)","volume":"437","author":"Yamashita","year":"2005","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2025.117210_b0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/jnc.13704","article-title":"Impact of disruption of secondary binding site S2 on dopamine transporter function. (in eng)","volume":"138","author":"Zhen","year":"2016","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.bcp.2025.117210_b0245","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nsmb.2894","article-title":"A mechanism for intracellular release of Na+ by neurotransmitter\/sodium symporters. (in eng)","volume":"21","author":"Malinauskaite","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117210_b0250","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aar6179","article-title":"Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT. (in eng)","volume":"4","author":"Merkle","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bcp.2025.117210_b0260","doi-asserted-by":"crossref","first-page":"11673","DOI":"10.1038\/ncomms11673","article-title":"A conserved leucine occupies the empty substrate site of LeuT in the Na(+)-free return state. (in eng)","volume":"7","author":"Malinauskaite","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117210_b0265","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41467-023-44637-6","article-title":"Ligand coupling mechanism of the human serotonin transporter differentiates substrates from inhibitors. (in eng)","volume":"15, no. 1","author":"Gradisch","year":"2024","journal-title":"Nat. Commun."},{"issue":"8025","key":"10.1016\/j.bcp.2025.117210_b0270","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41586-024-07739-9","article-title":"Structure of the human dopamine transporter and mechanisms of inhibition. (in eng)","volume":"632","author":"Srivastava","year":"2024","journal-title":"Nature"},{"issue":"8025","key":"10.1016\/j.bcp.2025.117210_b0275","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41586-024-07796-0","article-title":"Dopamine reuptake and inhibitory mechanisms in human dopamine transporter. (in eng)","volume":"632","author":"Li","year":"2024","journal-title":"Nature"},{"issue":"8015","key":"10.1016\/j.bcp.2025.117210_b0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41586-024-07437-6","article-title":"Dimerization and antidepressant recognition at noradrenaline transporter. (in eng)","volume":"630","author":"Zhang","year":"2024","journal-title":"Nature"},{"issue":"8026","key":"10.1016\/j.bcp.2025.117210_b0285","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41586-024-07638-z","article-title":"Transport and inhibition mechanisms of the human noradrenaline transporter. (in eng)","volume":"632","author":"Hu","year":"2024","journal-title":"Nature"},{"issue":"29","key":"10.1016\/j.bcp.2025.117210_b0290","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304602120","article-title":"Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants. (in eng)","volume":"120","author":"Yang","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117210_b0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/bs.apha.2023.09.004","article-title":"Cholesterol modulation of interactions between psychostimulants and dopamine transporters. (in eng)","volume":"99","author":"Chen","year":"2024","journal-title":"Adv. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117210_b0300","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41594-023-00983-z","article-title":"Molecular basis for substrate recognition and transport of human GABA transporter GAT1. (in eng)","volume":"30","author":"Zhu","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"49","key":"10.1016\/j.bcp.2025.117210_b0305","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl3857","article-title":"Illumination of serotonin transporter mechanism and role of the allosteric site. (in eng)","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"issue":"7552","key":"10.1016\/j.bcp.2025.117210_b0310","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature14431","article-title":"Neurotransmitter and psychostimulant recognition by the dopamine transporter. (in eng)","volume":"521","author":"Wang","year":"2015","journal-title":"Nature"},{"issue":"7915","key":"10.1016\/j.bcp.2025.117210_b0315","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41586-022-04814-x","article-title":"Structural basis of GABA reuptake inhibition. (in eng)","volume":"606","author":"Motiwala","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0320","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1038\/s41467-025-59066-w","article-title":"Molecular basis of human GABA transporter 3 inhibition. (in eng)","volume":"16","author":"Yadav","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117210_b0325","doi-asserted-by":"crossref","unstructured":"V. Eulenburg and S. H\u00fclsmann, \u201cSynergistic Control of Transmitter Turnover at Glycinergic Synapses by GlyT1, GlyT2, and ASC-1. (in eng), Int J Mol Sci. 23, no. 5. 2022, doi: 10.3390\/ijms23052561.","DOI":"10.3390\/ijms23052561"},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0330","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/02698811231161813","article-title":"Fifty years on: Serotonin and depression. (in eng)","volume":"37","author":"Jauhar","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bcp.2025.117210_b0335","doi-asserted-by":"crossref","unstructured":"A. Bahi, Serotonin transporter knockdown relieves depression-like behavior and ethanol-induced CPP in mice after chronic social defeat stress. (in eng), Behav Brain Res. 466, p. 114998. 28 2024, doi: 10.1016\/j.bbr.2024.114998.","DOI":"10.1016\/j.bbr.2024.114998"},{"key":"10.1016\/j.bcp.2025.117210_b0340","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jad.2018.06.034","article-title":"CSF miR-16 expression and its association with miR-16 and serotonin transporter in the raphe of a rat model of depression. (in eng)","volume":"238","author":"Shao","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2025.117210_b0345","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fnins.2017.00428","article-title":"miR-16 and fluoxetine both reverse autophagic and apoptotic change in chronic unpredictable mild stress model rats. (in eng)","volume":"11","author":"Yang","year":"2017","journal-title":"Front Neurosci"},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0895","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11030167","article-title":"The importance of epigenetics in diagnostics and treatment of major depressive disorder. (in eng)","volume":"11","author":"Czarny","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.bcp.2025.117210_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2024.105682","article-title":"Chronic social defeat stress induces anxiety-like behaviors via downregulation of serotonin transporter in the prefrontal serotonergic system in mice. (in eng)","volume":"174","author":"Araki","year":"2024","journal-title":"Neurochem. Int."},{"issue":"8","key":"10.1016\/j.bcp.2025.117210_b0355","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1038\/s41380-022-01661-0","article-title":"The serotonin theory of depression: a systematic umbrella review of the evidence. (in eng)","volume":"28","author":"Moncrieff","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100272","article-title":"\u201cIncreased methylation of NR3C1 and SLC6A4 is associated with blunted cortisol reactivity to stress in major depression. (in eng)","volume":"13","author":"Bakusic","year":"2020","journal-title":"Neurobiol. Stress"},{"issue":"20","key":"10.1016\/j.bcp.2025.117210_b0365","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2217\/epi-2022-0246","article-title":"Evaluation of DNA methylation in BDNF, SLC6A4, NR3C1 and FKBP5 before and after treatment with selective serotonin-reuptake inhibitor in major depressive disorder. (in eng)","volume":"14","author":"Mohammadi","year":"2022","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0370","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ijnp\/pyaa081","article-title":"Serotonin transporter gene promoter hypomethylation as a predictor of antidepressant treatment response in major depression: A replication study. (in eng)","volume":"24","author":"Schiele","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0375","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2006.03717.x","article-title":"The norepinephrine transporter and its regulation. (in eng)","volume":"97","author":"Mandela","year":"2006","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0380","doi-asserted-by":"crossref","first-page":"118","DOI":"10.31083\/j.fbl2903118","article-title":"Locus coeruleus-norepinephrine system: spheres of influence and contribution to the development of neurodegenerative diseases. (in eng)","volume":"29","author":"Nikolenko","year":"2024","journal-title":"Front, Biosci, (Landmark Ed)"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neuint.2011.11.003","article-title":"Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains. (in eng)","volume":"60","author":"Chen","year":"2012","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0390","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jnc.13761","article-title":"MicroRNAs 29b and 181a down-regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells. (in eng)","volume":"139","author":"Deng","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117210_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176801","article-title":"Etanercept ameliorates chronic mild stress-induced depressive-like behavior in rats: crosstalk between MAPK and STAT3 pathways and norepinephrine and serotonin transporters. (in eng)","volume":"978","author":"Fouad","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117210_b0400","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-related functional and structural dysconnectivity as a pathway to psychopathology. (in eng)","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0405","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fncel.2017.00253","article-title":"MAP kinase phosphatase 3 (MKP3) preserves norepinephrine transporter activity by modulating ERK1\/2 kinase-mediated gene expression","volume":"11","author":"Mortensen","year":"2017","journal-title":"(in eng), Front Cell Neurosci"},{"issue":"8","key":"10.1016\/j.bcp.2025.117210_b0410","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/pcn.13020","article-title":"Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression. (in eng)","volume":"74","author":"Moriya","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bcp.2025.117210_b0415","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jad.2019.10.041","article-title":"Lower midbrain dopamine transporter availability in depressed patients: report from high-resolution PET imaging. (in eng)","volume":"262","author":"Dubol","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.bcp.2025.117210_b0420","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jamapsychiatry.2019.0801","article-title":"Assessment of striatal dopamine transporter binding in individuals with major depressive disorder: in vivo positron emission tomography and postmortem evidence. (in eng)","volume":"76","author":"Pizzagalli","year":"2019","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0425","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41398-022-02080-z","article-title":"Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging. (in eng)","volume":"12","author":"Tamura","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0430","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1471-4159.2010.06788.x","article-title":"\u201cPKC links Gq-coupled receptors to DAT-mediated dopamine release. (in eng)","volume":"114","author":"Opazo","year":"2010","journal-title":"J. Neurochem."},{"issue":"16","key":"10.1016\/j.bcp.2025.117210_b0435","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1074\/jbc.RA120.012628","article-title":"Dopamine transporter trafficking and Rit2 GTPase: Mechanism of action and in vivo impact. (in eng)","volume":"295","author":"Fagan","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.102900","article-title":"Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function. (in eng)","volume":"299","author":"Kearney","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117210_b0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2016.04.051","article-title":"\u201cPKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux. (in eng)","volume":"622","author":"Wang","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2025.117210_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109787","article-title":"SiNiSan ameliorates depression-like behavior in rats by enhancing synaptic plasticity via the CaSR-PKC-ERK signaling pathway. (in eng)","volume":"124","author":"Shen","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117210_b0455","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fnmol.2018.00438","article-title":"Ca(2+) requirements for long-term depression are frequency sensitive in Purkinje cells. (in eng)","volume":"11","author":"Zamora Chimal","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bcp.2025.117210_b0460","doi-asserted-by":"crossref","first-page":"43468","DOI":"10.1038\/srep43468","article-title":"Increased PKC activity and altered GSK3\u03b2\/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces. (in eng)","volume":"7","author":"Garz\u00f3n-Ni\u00f1o","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117210_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105434","article-title":"Prolonged dopamine D(3) receptor stimulation promotes dopamine transporter ubiquitination and degradation through a PKC-dependent mechanism. (in eng)","volume":"165","author":"Luis-Ravelo","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0470","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41583-023-00724-7","article-title":"GABA tone regulation and its cognitive functions in the brain. (in eng)","volume":"24","author":"Koh","year":"2023","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117210_b0475","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14728222.2024.2383611","article-title":"Ways of modulating GABA transporters to treat neurological disease. (in eng)","volume":"28","author":"Mortensen","year":"2024","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bcp.2025.117210_b0480","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejpn.2025.03.015","article-title":"Update on inherited disorders of GABA metabolism. (in eng)","volume":"56","author":"Tokatly Latzer","year":"2025","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0485","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/EBC20220208","article-title":"Astrocytes regulate inhibitory neurotransmission through GABA uptake, metabolism, and recycling. (in eng)","volume":"67","author":"Andersen","year":"2023","journal-title":"Essays Biochem."},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117210_b0490","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuropharm.2016.10.019","article-title":"Novel, highly potent and invivo active inhibitor of GABA transporter subtype 1 with anticonvulsant, anxiolytic, antidepressant and antinociceptive properties. (in eng)","volume":"113","author":"Sa\u0142at","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117210_b0495","doi-asserted-by":"crossref","unstructured":"Y. Ying, W. Liu, H. Wang, J. Shi, Z. Wang, and J. Fei, \u201cGABA transporter mGat4 is involved in multiple neural functions in mice. (in eng), Biochim Biophys Acta Mol Cell Res. 1871, no. 5, p. 119740, Jun 2024, doi: 10.1016\/j.bbamcr.2024.119740.","DOI":"10.1016\/j.bbamcr.2024.119740"},{"key":"10.1016\/j.bcp.2025.117210_b0500","doi-asserted-by":"crossref","unstructured":"S. Wang et al. Decreased GABAergic signaling, fewer parvalbumin-, somatostatin- and calretinin-positive neurons in brain of a rat model of simulated transport stress. (in eng), Res Vet Sci. 134, pp. 86-95, Jan 2021, doi: 10.1016\/j.rvsc.2020.12.005.","DOI":"10.1016\/j.rvsc.2020.12.005"},{"issue":"4","key":"10.1016\/j.bcp.2025.117210_b0505","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/glia.24649","article-title":"Astrocytic GAT-3 regulates synaptic transmission and memory formation in the dentate gyrus. (in eng)","volume":"73","author":"Shen","year":"2025","journal-title":"Glia"},{"key":"10.1016\/j.bcp.2025.117210_b0510","doi-asserted-by":"crossref","unstructured":"W. Li et al. Activation of glycine receptors in the lateral habenula rescues anxiety- and depression-like behaviors associated with alcohol withdrawal and reduces alcohol intake in rats. (in eng), Neuropharmacology. 157, p. 107688, Oct 2019, doi: 10.1016\/j.neuropharm.2019.107688.","DOI":"10.1016\/j.neuropharm.2019.107688"},{"key":"10.1016\/j.bcp.2025.117210_b0515","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-319-55769-4_4","article-title":"Glycine transporters and its coupling with NMDA receptors. (in eng)","volume":"16","author":"Zafra","year":"2017","journal-title":"Adv. Neurobiol."},{"issue":"29","key":"10.1016\/j.bcp.2025.117210_b0520","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.2174\/1568026616666160405113340","article-title":"Inhibitors of glycine transporter-1: potential therapeutics for the treatment of CNS disorders. (in eng)","volume":"16","author":"Cioffi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2025.117210_b0525","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2013.02.020","article-title":"Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. (in eng)","volume":"74","author":"Huang","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0530","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neuint.2016.06.002","article-title":"Presynaptic control of inhibitory neurotransmitter content in VIAAT containing synaptic vesicles. (in eng)","volume":"98","author":"Aubrey","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bcp.2025.117210_b0535","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/biomedicines12071518","article-title":"Interactions involving glycine and other amino acid neurotransmitters: focus on transporter-mediated regulation of release and glycine-glutamate crosstalk. (in eng)","volume":"12","author":"Raiteri","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0540","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1037\/pha0000566","article-title":"Binding potential changes of SERT in patients with depression are associated with remission: A prospective [123I]\u03b2-CIT-SPECT study. (in eng)","volume":"31","author":"Krause","year":"2023","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0545","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1039\/D2MD00243D","article-title":"\u201cDesign, synthesis and evaluation of 1-(1,5-bis(4-substituted phenyl)-2-methyl-1H-pyrrol-3-yl)-N-methylmethanamines as SERT inhibitors with potential antidepressant action. (in eng)","volume":"14","author":"Wunnava","year":"2023","journal-title":"RSC Med. Chem."},{"issue":"22","key":"10.1016\/j.bcp.2025.117210_b0550","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1021\/jm501086v","article-title":"Loratadine and analogues: discovery and preliminary structure-activity relationship of inhibitors of the amino acid transporter B(0)AT2. (in eng)","volume":"57","author":"Cuboni","year":"2014","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biopsych.2017.10.008","article-title":"Antidepressants rescue stress-induced disruption of synaptic plasticity via serotonin transporter-independent inhibition of L-type calcium channels. (in eng)","volume":"84","author":"Normann","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0560","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ijms232315351","article-title":"\u201cFluoxetine enhances synaptic vesicle trafficking and energy metabolism in the hippocampus of socially isolated rats. (in eng)","volume":"23","author":"Filipovi\u0107","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0565","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-022-02389-y","article-title":"Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT(2B)R\/\u03b2-arrestin2 pathway. (in eng)","volume":"19","author":"Fang","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0570","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15622975.2023.2279958","article-title":"Repetitive transcranial magnetic stimulation and fluoxetine attenuate astroglial activation and benefit behaviours in a chronic unpredictable mild stress mouse model of depression. (in eng)","volume":"25","author":"Yuan","year":"2024","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173449","article-title":"Synergistic antidepressant effects of citalopram and SB-334867 in the REM sleep-deprived mice: Possible role of BDNF. (in eng)","volume":"219","author":"Saadati","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"22","key":"10.1016\/j.bcp.2025.117210_b0580","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.2174\/0929867330666230623163315","article-title":"miR-204-5p plays a critical role in the pathogenesis of depression and anti-depression action of venlafaxine in the hippocampus of mice. (in eng)","volume":"31","author":"Guan","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117210_b0585","doi-asserted-by":"crossref","unstructured":"V. C. C. Capibaribe et al. Thymol reverses depression-like behaviour and upregulates hippocampal BDNF levels in chronic corticosterone-induced depression model in female mice. (in eng), J Pharm Pharmacol. 71, 12, pp. 1774-1783, Dec 2019, doi: 10.1111\/jphp.13162.","DOI":"10.1111\/jphp.13162"},{"key":"10.1016\/j.bcp.2025.117210_b0590","doi-asserted-by":"crossref","unstructured":"J. Zhang et al. Fluoxetine shows neuroprotective effects against LPS-induced neuroinflammation via the Notch signaling pathway. (in eng), Int Immunopharmacol. 113, no. Pt A, p. 109417, Dec 2022, doi: 10.1016\/j.intimp.2022.109417.","DOI":"10.1016\/j.intimp.2022.109417"},{"issue":"14","key":"10.1016\/j.bcp.2025.117210_b0595","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147483","article-title":"Escitalopram targets oxidative stress, caspase-3, BDNF and MeCP2 in the hippocampus and frontal cortex of a rat model of depression induced by chronic unpredictable mild stress. (in eng)","volume":"22","author":"Dionisie","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117210_b0600","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/jpp\/rgaa003","article-title":"\u201cProtective effects of duloxetine against chronic immobilisation stress-induced anxiety, depression, cognitive impairment and neurodegeneration in mice. (in eng)","volume":"73","author":"Meejuru","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117210_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116184","article-title":"\u201cIntranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences. (in eng)","volume":"223","author":"Silva","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117210_b0610","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ejpb.2023.12.002","article-title":"Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression. (in eng)","volume":"194","author":"Silva","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bcp.2025.117210_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112708","article-title":"The antidepressant-like effects of fluvoxamine in mice involve the mTOR signaling in the hippocampus and prefrontal cortex. (in eng)","volume":"285","author":"Xu","year":"2020","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bcp.2025.117210_b0620","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jad.2020.07.096","article-title":"Venlafaxine protects against chronic stress-related behaviors in mice by activating the mTORC1 signaling cascade. (in eng)","volume":"276","author":"Wang","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2025.117210_b0625","doi-asserted-by":"crossref","unstructured":"Y. Wu et al. Levomilnacipran Improves Lipopolysaccharide-Induced Dysregulation of Synaptic Plasticity and Depression-Like Behaviors via Activating BDNF\/TrkB Mediated PI3K\/Akt\/mTOR Signaling Pathway. (in eng). Mol Neurobiol. 61(7) 2024. 4102-4115. Doi: 10.1007\/s12035-023-03832-8.","DOI":"10.1007\/s12035-023-03832-8"},{"issue":"10","key":"10.1016\/j.bcp.2025.117210_b0630","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1017\/S0033291722001805","article-title":"Acute neural effects of fluoxetine on emotional regulation in depressed adolescents. (in eng)","volume":"53","author":"Capit\u00e3o","year":"2023","journal-title":"Psychol. Med."},{"issue":"10","key":"10.1016\/j.bcp.2025.117210_b0635","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/cap.2023.0048","article-title":"Efficacy of preventing relapse evaluated by a multicenter randomized double-blind placebo-controlled withdrawal study of escitalopram in japanese adolescents with major depressive disorder. (in eng)","volume":"33","author":"Saito","year":"2023","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.bcp.2025.117210_b0640","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jad.2024.02.002","article-title":"The efficacy and safety of sertraline in maintenance hemodialysis patients with depression: A randomized controlled study. (in eng)","volume":"352","author":"Zhang","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0645","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1017\/S1092852924000245","article-title":"Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder. (in eng)","volume":"29","author":"McIntyre","year":"2024","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bcp.2025.117210_b0650","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2024.06.003","article-title":"\u201cCognitive improvement in late-life depression treated with vortioxetine and duloxetine in an eight-week randomized controlled trial: The role of age at first onset and change in depressive symptoms. (in eng)","volume":"361","author":"Xue","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0655","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/psyg.12475","article-title":"Cortical thickness increases with levomilnacipran treatment in a pilot randomised double-blind placebo-controlled trial in late-life depression. (in eng)","volume":"20","author":"Krause-Sorio","year":"2020","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.bcp.2025.117210_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135585","article-title":"Clinical serum metabolomics study on fluoxetine hydrochloride for depression. (in eng)","volume":"746","author":"Shen","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0665","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12888-024-05724-0","article-title":"The relationship between serum resolvin D1, NLRP3, cytokine levels, and adolescents with first-episode medication-na\u00efve major depressive disorder. (in eng)","volume":"24","author":"Guo","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0670","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/jamaneurol.2021.2418","article-title":"\u201cDepression outcomes among patients treated with fluoxetine for stroke recovery: The AFFINITY randomized clinical trial. (in eng)","volume":"78","author":"Almeida","year":"2021","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0675","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/17474930221124760","article-title":"Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the efficacy of fluoxetine-a randomized controlled trial in stroke trial data set. (in eng)","volume":"18","author":"Tay","year":"2023","journal-title":"Int. J. Stroke"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0680","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12888-024-05833-w","article-title":"The safety and efficacy of escitalopram and sertraline in post-stroke depression: a randomized controlled trial. (in eng)","volume":"24","author":"Yan","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0685","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13136","article-title":"Citalopram for acute and preventive efficacy in bipolar depression (CAPE-BD): A randomized, double-blind, placebo-controlled trial. (in eng)","volume":"82","author":"Ghaemi","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0690","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpsychires.2021.04.035","article-title":"Neural correlates of citalopram and placebo response in acute bipolar depression: A randomized trial. (in eng)","volume":"138","author":"Sretavan Wong","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.bcp.2025.117210_b0695","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1056\/NEJMoa2300184","article-title":"Duration of adjunctive antidepressant maintenance in bipolar I depression. (in eng)","volume":"389","author":"Yatham","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0700","doi-asserted-by":"crossref","first-page":"436","DOI":"10.34067\/KID.0000062020","article-title":"Depression and the effect of sertraline on inflammatory biomarkers in patients with nondialysis CKD. (in eng)","volume":"1","author":"Gregg","year":"2020","journal-title":"Kidney360"},{"key":"10.1016\/j.bcp.2025.117210_b0705","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56427","article-title":"Chemical and structural investigation of the paroxetine-human serotonin transporter complex. (in eng)","volume":"9","author":"Coleman","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0710","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/s41467-021-22385-9","article-title":"\u201cStructural basis of norepinephrine recognition and transport inhibition in neurotransmitter transporters. (in eng)","volume":"12","author":"Pidathala","year":"2021","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.bcp.2025.117210_b0715","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.cell.2023.04.010","article-title":"Structure-based discovery of conformationally selective inhibitors of the serotonin transporter. (in eng)","volume":"186","author":"Singh","year":"2023","journal-title":"Cell"},{"issue":"6618","key":"10.1016\/j.bcp.2025.117210_b0720","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1126\/science.abo3566","article-title":"Design of fast-onset antidepressant by dissociating SERT from nNOS in the DRN. (in eng)","volume":"378","author":"Sun","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bcp.2025.117210_b0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2025.110425","article-title":"Unveiling the potential abuse liability of \u03b1-D2PV: A novel \u03b1-carbon phenyl-substituted synthetic cathinone. (in eng)","volume":"272","author":"Nadal-Gratac\u00f3s","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2025.117210_b0730","doi-asserted-by":"crossref","unstructured":"M. El Fadili et al. QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties. (in eng), Heliyon. 9(2) 2023 e13706. doi: 10.1016\/j.heliyon.2023.e13706.","DOI":"10.1016\/j.heliyon.2023.e13706"},{"issue":"11","key":"10.1016\/j.bcp.2025.117210_b0735","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1021\/acschemneuro.0c00602","article-title":"Structural determinants of the neuronal glycine transporter 2 for the selective inhibitors ALX1393 and ORG25543. (in eng)","volume":"12","author":"Benito-Mu\u00f1oz","year":"2021","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2025.117210_b0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116564","article-title":"Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile. (in eng)","volume":"275","author":"Zheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2025.117210_b0745","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/acschemneuro.1c00078","article-title":"Novel potent dopamine-norepinephrine and triple reuptake uptake inhibitors based on asymmetric pyran template and their molecular interactions with monoamine transporters. (in eng)","volume":"12","author":"Santra","year":"2021","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bcp.2025.117210_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172632","article-title":"D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats. (in eng)","volume":"862","author":"Dutta","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2025.117210_b0755","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234218","article-title":"Electrophysiology and behavioral assessment of the new molecule SMe1EC2M3 as a representative of the future class of triple reuptake inhibitors. (in eng)","volume":"24","author":"Koprdova","year":"2019","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0760","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/toxsci\/kfr013","article-title":"Assessment of biomarkers of drug-induced kidney injury in cynomolgus monkeys treated with a triple reuptake inhibitor. (in eng)","volume":"120","author":"Guha","year":"2011","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bcp.2025.117210_b0765","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yrtph.2018.10.008","article-title":"Toxicity effects of a novel potent triple reuptake inhibitor, LPM570065, on the fertility and early embryonic development in Sprague-Dawley rats. (in eng)","volume":"100","author":"Guo","year":"2018","journal-title":"Regul. Toxicol. Pharm."},{"issue":"14","key":"10.1016\/j.bcp.2025.117210_b0770","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147881","article-title":"Effects of SRI-32743, a novel quinazoline structure-based compound, on HIV-1 tat and cocaine interaction with norepinephrine transporter. (in eng)","volume":"25","author":"Jim\u00e9nez-Torres","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117210_b0775","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12916-016-0560-3","article-title":"Cognitive remission: a novel objective for the treatment of major depression?. (in eng)","volume":"14","author":"Bortolato","year":"2016","journal-title":"BMC Med."},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0780","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1021\/acs.jmedchem.4c02549","article-title":"Exploring simple drug scaffolds from the generated database chemical space reveals a chiral bicyclic azepane with potent neuropharmacology. (in eng)","volume":"68","author":"Carrel","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0900","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jep.2014.03.066","article-title":"\u201cAntiinflammatory and neurological activity of pyrithione and related sulfur-containing pyridine N-oxides from Persian shallot (Allium stipitatum). (in eng)","volume":"154","author":"Krej\u010dov\u00e1","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117210_b0905","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.sjbs.2020.07.003","article-title":"HPLC-PDA-MS\/MS profiling of secondary metabolites from Opuntia ficus-indica cladode, peel and fruit pulp extracts and their antioxidant, neuroprotective effect in rats with aluminum chloride induced neurotoxicity. (in eng)","volume":"27","author":"El-Hawary","year":"2020","journal-title":"Saudi J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0790","doi-asserted-by":"crossref","DOI":"10.3390\/ph15030344","article-title":"Two Lignan glycosides from Albizia julibrissin Durazz. Noncompetitively inhibit serotonin transporter. (in eng)","volume":"15","author":"Huang","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"12","key":"10.1016\/j.bcp.2025.117210_b0795","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121637","article-title":"(-)-Syringaresinol exerts an antidepressant-like activity in mice by noncompetitive inhibition of the serotonin transporter. (in eng)","volume":"17","author":"Wu","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/j.bcp.2025.117210_b0800","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1039\/D0FO03340E","article-title":"Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome via colonic mast cell activation and central 5-hydroxytryptamine metabolism. (in eng)","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct"},{"key":"10.1016\/j.bcp.2025.117210_b0910","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154871","article-title":"Antidepressant effects of p-coumaric acid isolated from Vaccinium bracteatum leaves extract on chronic restraint stress mouse model and antagonism of serotonin 6 receptor in vitro. (in eng)","volume":"116","author":"Oh","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117210_b0785","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1425485","article-title":"Exploring the sedative properties of natural molecules from hop cones (Humulus lupulus) as promising natural anxiolytics through GABA receptors and the human serotonin transporter. (in eng)","volume":"12","author":"Belal","year":"2024","journal-title":"Front Chem"},{"key":"10.1016\/j.bcp.2025.117210_b0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2019.112061","article-title":"Mesembrine: The archetypal psycho-active Sceletium alkaloid. (in eng)","volume":"166","author":"Makolo","year":"2019","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0920","doi-asserted-by":"crossref","first-page":"15114","DOI":"10.1038\/s41598-017-15483-6","article-title":"Novel serotonin transporter regulators: Natural aristolane- and nardosinane- types of sesquiterpenoids from Nardostachys chinensis Batal. (in eng)","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117210_b0925","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fphar.2018.00604","article-title":"Vaccinium bracteatum leaf extract reverses chronic restraint stress-induced depression-like behavior in mice: regulation of hypothalamic-pituitary-adrenal axis, serotonin turnover systems, and ERK\/Akt phosphorylation (in eng)","volume":"9","author":"Oh","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117210_b0930","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23102536","article-title":"Bioinspired honokiol analogs and their evaluation for activity on the norepinephrine transporter. (in eng)","volume":"23","author":"Stout","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0935","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26010022","article-title":"Anti-inflammatory and neuromodulatory effects induced by Tanacetum parthenium water extract: results from in silico, in vitro and ex vivo studies. (in eng)","volume":"26","author":"Recinella","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117210_b0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113451","article-title":"Alkaloids extracted from Uncaria rhynchophylla demonstrate neuroprotective effects in MPTP-induced experimental parkinsonism by regulating the PI3K\/Akt\/mTOR signaling pathway. (in eng)","volume":"266","author":"Zheng","year":"2021","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0945","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1017\/cjn.2017.268","article-title":"Effects of Ginkgo Biloba Extract on A53T \u03b1-synuclein transgenic mouse models of Parkinson's disease. (in eng)","volume":"45","author":"Kuang","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0950","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s11655-019-2944-7","article-title":"Pinellia total alkaloids modulate the GABAergic system in hippocampal formation on pilocarpine-induced epileptic rats. (in eng)","volume":"26","author":"Deng","year":"2020","journal-title":"Chin. J. Integr. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0955","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030385","article-title":"Ginseng gintonin attenuates lead-induced rat cerebellar impairments during gestation and lactation. (in eng)","volume":"10","author":"Nam","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bcp.2025.117210_b0960","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00018-024-05309-w","article-title":"Unveiling the crucial role of betaine: modulation of GABA homeostasis via SLC6A1 transporter (GAT1). (in eng)","volume":"81","author":"Bhatt","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117210_b0805","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S2215-0366(23)00262-6","article-title":"Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool development. (in eng)","volume":"10","author":"Pillinger","year":"2023","journal-title":"Lancet Psychiatry"},{"issue":"8","key":"10.1016\/j.bcp.2025.117210_b0810","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/s41386-024-01826-1","article-title":"Potential therapeutics for effort-related motivational dysfunction: assessing novel atypical dopamine transport inhibitors. (in eng)","volume":"49","author":"Ecevitoglu","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0815","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114204120","article-title":"Persistent binding at dopamine transporters determines sustained psychostimulant effects. (in eng)","volume":"120","author":"Niello","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2025.117210_b0820","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/bs.apha.2023.10.006","article-title":"Modafinil, an atypical CNS stimulant?. (in eng)","volume":"99","author":"Hersey","year":"2024","journal-title":"Adv. Pharmacol."},{"issue":"13","key":"10.1016\/j.bcp.2025.117210_b0825","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135270","article-title":"Are there prevalent sex differences in psychostimulant use disorder? A focus on the potential therapeutic efficacy of atypical dopamine uptake inhibitors. (in eng)","volume":"28","author":"Hersey","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117210_b0830","article-title":"Critical role of astrocytic polyamine and GABA metabolism in epileptogenesis. (in eng)","volume":"15","author":"Kov\u00e1cs","year":"2021","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0835","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/epi4.12741","article-title":"Discovery of E2730, a novel selective uncompetitive GAT1 inhibitor, as a candidate for anti-seizure medication. (in eng)","volume":"8","author":"Fukushima","year":"2023","journal-title":"Epilepsia Open"},{"issue":"11","key":"10.1016\/j.bcp.2025.117210_b0840","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1111\/epi.18119","article-title":"In vivo biomarkers of GABAergic function in epileptic rats treated with the GAT-1 inhibitor E2730. (in eng)","volume":"65","author":"Ali","year":"2024","journal-title":"Epilepsia"},{"key":"10.1016\/j.bcp.2025.117210_b0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107364","article-title":"Pharmacological evaluation of E2730, a novel selective uncompetitive GAT1 inhibitor, on epileptiform activities in resected brain tissues from human focal cortical dysplasia ex vivo. (in eng)","volume":"202","author":"Kitaura","year":"2024","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0850","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biopsych.2024.08.019","article-title":"Finding the right dose: NMDA receptor-modulating treatments for cognitive and plasticity deficits in schizophrenia and the role of pharmacodynamic target engagement. (in eng)","volume":"97","author":"Sehatpour","year":"2025","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2025.117210_b0855","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/med.22086","article-title":"Current emerging therapeutic targets and clinical investigational agents for schizophrenia: challenges and opportunities. (in eng)","volume":"45","author":"Ye","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bcp.2025.117210_b0860","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.2147\/NDT.S501560","article-title":"A clinically oriented review of new antipsychotics for Schizophrenia. (in eng)","volume":"20","author":"Luca","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0865","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/acschemneuro.5c00039","article-title":"Effect of SSR504734, a selective glycine transporter type 1 inhibitor, on seizure thresholds, neurotransmitter levels, and inflammatory markers in mice. (in eng)","volume":"16","author":"Gapi\u0144ska","year":"2025","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bcp.2025.117210_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111209","article-title":"Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. (in eng)","volume":"194","author":"Rana","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"6","key":"10.1016\/j.bcp.2025.117210_b0870","doi-asserted-by":"crossref","DOI":"10.3390\/biom11060864","article-title":"Inhibition of glycine re-uptake: A potential approach for treating pain by augmenting glycine-mediated spinal neurotransmission and blunting central nociceptive signaling. (in eng)","volume":"11","author":"Cioffi","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.117210_b0875","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pnpbp.2019.02.001","article-title":"The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders. (in eng)","volume":"92","author":"Peyrovian","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117210_b0880","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2024.08.026","article-title":"Efficacy and safety of add-on sarcosine in patients with major depressive disorder: A randomized controlled trial. (in eng)","volume":"178","author":"Padhan","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117210_b0890","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"\u201cNatural products in drug discovery: advances and opportunities. (in eng)","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T22:37:22Z","timestamp":1761777442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":191,"alternative-id":["S0006295225004757"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117210","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SLC6 transporters as pharmacological targets in depression: Molecular mechanisms and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117210"}}